Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C
- 1 June 1996
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 41 (6), 1276-1277
- https://doi.org/10.1007/bf02088249
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis: A 12-month double-blind, placebo-controlled trialJournal of Hepatology, 1994
- Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialJournal of Hepatology, 1993
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992
- Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection.Proceedings of the National Academy of Sciences, 1992
- Significance of Igm Antibody to Hepatitis C Virus in Patients With Chronic Hepatitis CHepatology, 1992
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytesHepatology, 1990
- Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosisHepatology, 1990
- Hepatic Expression of Class I and Class Ii Major Histocompatibility Complex Molecules in Primary Biliary Cirrhosis: Effect of Ursodeoxycholic AcidHepatology, 1990